Kepler Cheuvreux cuts LEM Holding stock rating to hold, lowers target

Kepler Cheuvreux downgraded LEM Holding SA (LEHN:SW) from Buy to Hold, lowering the price target to CHF 850.00 from CHF 1,050.00 ahead of its FY25 results on May 27. While LEM Holding anticipates a recovery later in the year and expects a high-single-digit EBIT margin due to its Fit for Growth program, weak sales volumes and modest order levels have tempered expectations for revenue growth, projected to be similar to the previous year. The revised price target reflects a slower-than-anticipated recovery and its potential impact on the company's financial performance.

Analysis

Kepler Cheuvreux has recalibrated its outlook on LEM Holding SA (LEHN:SW), downgrading the stock from Buy to Hold and reducing the price target to CHF 850.00 from CHF 1,050.00, a decision influenced by a slower-than-anticipated recovery ahead of the company’s May 27 financial year 2025 results announcement. While LEM Holding's management anticipates a potential recovery towards the end of the year and projects an EBIT margin in the high-single-digit range, excluding one-off costs, due to early positive impacts from its "Fit for Growth" program, the company currently faces weakness across all its end-markets. Despite a gradual improvement in the book-to-bill ratio, low sales volumes and modest absolute order levels have led management to project a revenue performance for the upcoming year similar to the previous one. This tempered outlook and the delayed recovery assumptions, which underpin Kepler Cheuvreux's revised valuation, highlight the challenging market conditions impacting LEM Holding's future financial performance, a view subtly reinforced by an external InvestingPro AI analysis suggesting the stock may not currently be a top pick for undervaluation.

Key Decisions for Investors

• Investors should consider the implications of Kepler Cheuvreux's downgrade and CHF 200.00 price target reduction, which signals increased caution regarding LEM Holding's near-term prospects.
• It is advisable to await LEM Holding's full-year results on May 27 for critical insights into actual financial performance, the tangible impact of the "Fit for Growth" program on EBIT margins, and any revisions to management's revenue outlook.
• Monitor key leading indicators such as order intake, sales volume, and the book-to-bill ratio for concrete evidence of the anticipated market recovery before making significant investment adjustments.
• Factor in the external AI-driven valuation assessment, which suggests LEHN may not be significantly undervalued, when evaluating the stock's current market price and risk-reward profile.